Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid, Instrumentation Laboratories to Develop Hemostasis Dxs; IL to Market Them

NEW YORK (GenomeWeb News) — Cepheid and Instrumentation Laboratory intend to develop and distribute diagnostics for hemostasis applications, Cepheid said today.  
Under the agreement, Cepheid will develop tests to be used on its GeneXpert technology, while IL will market them as part of its panel of hemostasis diagnostic assays.
Cepheid said it first plans to develop the Xpert HemosIL tests to detect Factor II and Factor V mutations, which are genetic variations associated with thrombosis.
Financial terms of the agreement were not disclosed.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.